Insmed PARI milestones — Intangibles, net decreased by 5.3% to $911.00K in Q1 2026 compared to the prior quarter.
A higher value indicates a larger portfolio of active, capitalized intellectual property, while a decrease suggests amortization or potential impairment of these assets.
This represents the net book value of intangible assets acquired through milestone-based agreements related to the PARI...
Comparable to capitalized in-process research and development or acquired licensing rights at other biopharmaceutical firms.
insm_segment_pari_milestones_intangibles_net| Q4 '23 | Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $1.37M | $1.16M | $1.01M | $962.00K | $911.00K |
| QoQ Change | — | -14.8% | -13.0% | -5.0% | -5.3% |
| YoY Change | — | -14.8% | — | -17.4% | — |